319 related articles for article (PubMed ID: 27153100)
1. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.
Cornelissen LA; Van Vliet SJ
Biomolecules; 2016 May; 6(2):. PubMed ID: 27153100
[TBL] [Abstract][Full Text] [Related]
2. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
[TBL] [Abstract][Full Text] [Related]
3. Antibody recognition of aberrant glycosylation on the surface of cancer cells.
Soliman C; Yuriev E; Ramsland PA
Curr Opin Struct Biol; 2017 Jun; 44():1-8. PubMed ID: 27821276
[TBL] [Abstract][Full Text] [Related]
4. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
[TBL] [Abstract][Full Text] [Related]
5. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
6. Simple sugars to complex disease--mucin-type O-glycans in cancer.
Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
[TBL] [Abstract][Full Text] [Related]
7. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
Carvalho S; Reis CA; Pinho SS
Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
[TBL] [Abstract][Full Text] [Related]
8. Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet.
Hockl PF; Wolosiuk A; Pérez-Sáez JM; Bordoni AV; Croci DO; Toum-Terrones Y; Soler-Illia GJ; Rabinovich GA
Pharmacol Res; 2016 Jul; 109():45-54. PubMed ID: 26855319
[TBL] [Abstract][Full Text] [Related]
9. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
10. A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
Audfray A; Beldjoudi M; Breiman A; Hurbin A; Boos I; Unverzagt C; Bouras M; Lantuejoul S; Coll JL; Varrot A; Le Pendu J; Busser B; Imberty A
PLoS One; 2015; 10(6):e0128190. PubMed ID: 26042789
[TBL] [Abstract][Full Text] [Related]
11. A Sweet Warning: Mucin-Type O-Glycans in Cancer.
Zhang Y; Sun L; Lei C; Li W; Han J; Zhang J; Zhang Y
Cells; 2022 Nov; 11(22):. PubMed ID: 36429094
[TBL] [Abstract][Full Text] [Related]
12. Analysis of tumor-associated mucin glycotopes by Western transfer methods.
Gnanapragassam VS; Jain M; Batra SK
Methods Mol Biol; 2013; 980():331-40. PubMed ID: 23359164
[TBL] [Abstract][Full Text] [Related]
13. Atlantic Salmon Carries a Range of Novel O-Glycan Structures Differentially Localized on Skin and Intestinal Mucins.
Jin C; Padra JT; Sundell K; Sundh H; Karlsson NG; Lindén SK
J Proteome Res; 2015 Aug; 14(8):3239-51. PubMed ID: 26066491
[TBL] [Abstract][Full Text] [Related]
14. Bitter-sweet symphony: glycan-lectin interactions in virus biology.
Van Breedam W; Pöhlmann S; Favoreel HW; de Groot RJ; Nauwynck HJ
FEMS Microbiol Rev; 2014 Jul; 38(4):598-632. PubMed ID: 24188132
[TBL] [Abstract][Full Text] [Related]
15. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
16. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA.
Jerome KR; Bu D; Finn OJ
Cancer Res; 1992 Nov; 52(21):5985-90. PubMed ID: 1382849
[TBL] [Abstract][Full Text] [Related]
18. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
Lange T; Samatov TR; Tonevitsky AG; Schumacher U
Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
[TBL] [Abstract][Full Text] [Related]
19. Mucin O-glycan microarrays.
Li Z; Chai W
Curr Opin Struct Biol; 2019 Jun; 56():187-197. PubMed ID: 31063936
[TBL] [Abstract][Full Text] [Related]
20. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
Sato S; St-Pierre C; Bhaumik P; Nieminen J
Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
